Molecular Imaging: a Market estimated to be worth US$45 billion by 2010

(PRWEB) May 14, 2004 -- Research and Markets announces the addition of this new report entitled "The Executive Guide to Molecular Imaging" to its offerings.

A plain-English review of the research, technology and developers that are driving this area of high interest. A market estimated to be worth US$45 billion by 2010.

Molecular imaging (MI) is the measurement and imaging of biological processes in living organisms at the molecular and cellular level. It is a newly-evolving technology which combines molecular agents with advanced imaging tools to capture pictures of specific molecular pathways in the body, particularly disease targets. It could transform healthcare and the health industry.

The clinical benefits of this technology are clear. If potentially lethal conditions such as cancer or cardiovascular disease can be detected before they have taken hold, patient outcomes would improve vastly and healthcare costs would decline as the need for surgery or later-stage treatments decrease.

The commercial opportunities are no less impressive. Pharmaceutical developers can use information gained to identify and develop drugs that target specific molecular structures, while imaging and diagnostic companies have much to gain from the need for advanced imaging equipment and contrast media.

This highly informative 100-page report is based on extensive primary academic and commercial research. The report distils the current thinking on MI and identifies the companies and organisations that are developing products/technology.

Extensive contents include:
Molecular Imaging Background
Medical Device Companies
Including:
-ABX Advanced Biochemical Compounds
-Advanced Research Technologies
-Bioscan
-CTI Molecular Imaging
-Cytogen
-Gamma Medica
-GE Medical Systems
-Immunomedics
-Kereos
-Lightools Research
-Mediscience Technology
-Mallinckrodt (Tyco)
-Macrocyclics
-Philips Medical Systems
-Schering
-Siemens Medical Solutions

Academic & Research Institutes Worldwide

The work of over 25 institutions including:
-Harvard Medical School
-John Hopkins University
-Mayo Clinic
-National Cancer Institute
-NIH
-NIBIB
-Stanford University
-University of California
-VA Medical Centre
-Washington University
-University Hospital Innsbruck
-Universities of Hamburg and Marburg
-Centre of Molecular Imaging (Norway)
-Uppsala University
-Queens University, Belfast
-University of Manchester

For a complete index of this report click on http://www.researchandmarkets.com/reports/72061

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com